Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Pain
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Pain
    TopAbstracts in Pain 11/27/2008 - (DGNews)
    FDA Approves Tapentadol for Relief of Moderate to Severe Acute Pain - (DGNews)
    TopAbstracts in Pain 11/20/2008 - (DGNews)
    TopAbstracts in Pain 11/13/2008 - (DGNews)
    TopAbstracts in Pain 11/06/2008 - (DGNews)

    News archive

     Recent webcasts/CME - Pain
      Chronic Pain Patients on Opioid Therapy
      Chronic Pain Management in Primary Care: Individualizing Pain Relief and Improving Quality of Life
      Acute Pain Management and Opioid Treatment: Community Pharmacist Perspectives
      Enhanced NSAID Delivery: Emerging Technologies
      Balanced Opioid Prescribing

      Webcasts/CME archive

       Recent cases - Pain
        Pain in Both Knees
        Ketamine as an Adjuvant in Sympathetic Blocks for Management of Central Sensitization Following Peripheral Nerve Injury
        Sciatica Due to Extrapelvic Heterotopic Ossification: A Case Report
        Factitious Lymphoedema as a Psychiatric Condition Mimicking Reflex Sympathetic Dystrophy: A Case Report
        Gluteal Pyomyositis as a Rare Cause of Sciatica in a Temperate Region: A Case Report

        Cases archive
          




        my personal edition > pain > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Duloxetine May Alleviate Both Pain and General Anxiety Disorder: Presented at AAPM

        By Jerry Ingram

        NEW ORLEANS, LA -- February 12, 2007 -- Duloxetine appears to offer pain relief for patients with both general anxiety disorder (GAD) and painful physical symptoms, according to research presented here at the American Academy of Pain Medicine 23rd Annual Meeting (AAPM).

        "We wanted to look at patients with general anxiety disorder as well as pain. What we found is that patients presenting with anxiety also presented with pain," explained study author Andrea Collier-Johnson, PharmD, medical liaison, Eli Lilly, Indianapolis, Indiana.

        For this investigation researchers pooled and analyzed data from 2 randomized, double-blind studies. In the first study, clinicians assigned 168 patients to duloxetine 60 mg per day, 170 patients to duloxetine 120 mg per day, and 175 to placebo. They carried out the study for 9 weeks.

        The second study was a 10-week investigation that included a flexible-dose approach with patients in the duloxetine group (n = 168) receiving between 60 and 120 mg per day and 159 patients in the placebo group.

        The Hamilton Anxiety Scale (HAMA), the Visual Analogue Scales (VAS) for pain and the Sheehan Disability Scale (SDS) were used as primary and secondary measures of efficacy.

        Results show that patients in the duloxetine group reported significantly greater improvements in anxiety symptoms (HAMA total score) compared with patients receiving placebo (P = .017), and on patient functioning as determined with the SDS (P < .001).

        Patients also experienced improvement in function in the areas of work and school (P = .001), social life (P < .001), and management of family and home life (P < .001).

        Patients in the duloxetine group also experienced significantly greater improvements compared with placebo-treated patients on 5 of 6 VAS pain items, the researchers reported.

        "Overall, we concluded from these 2 studies that patients with generalized anxiety disorder treated with duloxetine did very well, improving their lives as well as decreasing their level of pain," Dr. Collier-Johnson concluded.


        [Presentation title: Efficacy of Duloxetine in the Treatment of Generalized Anxiety Disorder in Patients With Clinically Significant Painful Physical Symptoms. Poster 112]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send